United States
The US Drug Enforcement Administration has classified the narcolepsy medication oveporexton under Schedule IV, with the rule taking effect on November 12.
The drug, oveporexton, which was approved in August for treating adults with narcolepsy type 1, has been placed in Schedule IV by the Drug Enforcement Administration. This classification was made through an interim final rule that became effective on November 12.
This information is based on a report by Econotimes.
The US dollar has strengthened as market participants anticipate further interest rate increases from the Federal Reserve.
Solana (SOL) experienced a 2.50% decrease in value over a one-hour period, coinciding with liquidations totaling $15.16 million.
Ranbir Kapoor's latest film, 'Ramayana', has achieved a significant milestone, crossing ₹1,100 crore in worldwide box office collections. The film is now setting its sights on surpassing the lifetime business of 'Jawan'.
